Clinical Trial Update: Corticosteroid Therapy in Refractory Shock Following Cardiac Arrest [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating corticosteroid therapy for refractory shock after cardiac arrest has completed, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Arrest

Drugs mentioned

• Corticosteroids (corticosteroids)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Cardiac Arrest | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-05-17